JP2022531205A5 - - Google Patents
Info
- Publication number
- JP2022531205A5 JP2022531205A5 JP2021564373A JP2021564373A JP2022531205A5 JP 2022531205 A5 JP2022531205 A5 JP 2022531205A5 JP 2021564373 A JP2021564373 A JP 2021564373A JP 2021564373 A JP2021564373 A JP 2021564373A JP 2022531205 A5 JP2022531205 A5 JP 2022531205A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025014950A JP2025072444A (ja) | 2019-04-30 | 2025-01-31 | 抗ｒｓｖ抗体の投与レジメン及び抗ｒｓｖ抗体を含む組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840701P | 2019-04-30 | 2019-04-30 | |
| US62/840,701 | 2019-04-30 | ||
| PCT/US2020/030619 WO2020223435A1 (en) | 2019-04-30 | 2020-04-30 | Dosage regimens for and compositions including anti-rsv antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014950A Division JP2025072444A (ja) | 2019-04-30 | 2025-01-31 | 抗ｒｓｖ抗体の投与レジメン及び抗ｒｓｖ抗体を含む組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022531205A JP2022531205A (ja) | 2022-07-06 |
| JPWO2020223435A5 JPWO2020223435A5 (https=) | 2023-05-11 |
| JP2022531205A5 true JP2022531205A5 (https=) | 2023-05-11 |
Family
ID=70779897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564373A Pending JP2022531205A (ja) | 2019-04-30 | 2020-04-30 | 抗ｒｓｖ抗体の投与レジメン及び抗ｒｓｖ抗体を含む組成物 |
| JP2025014950A Pending JP2025072444A (ja) | 2019-04-30 | 2025-01-31 | 抗ｒｓｖ抗体の投与レジメン及び抗ｒｓｖ抗体を含む組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014950A Pending JP2025072444A (ja) | 2019-04-30 | 2025-01-31 | 抗ｒｓｖ抗体の投与レジメン及び抗ｒｓｖ抗体を含む組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US12024553B2 (https=) |
| EP (1) | EP3962940A1 (https=) |
| JP (2) | JP2022531205A (https=) |
| KR (1) | KR20220002427A (https=) |
| CN (1) | CN113825767A (https=) |
| AU (1) | AU2020265676A1 (https=) |
| BR (1) | BR112021020846A2 (https=) |
| CA (1) | CA3138180A1 (https=) |
| CO (1) | CO2021014370A2 (https=) |
| EA (1) | EA202192776A1 (https=) |
| IL (1) | IL287443A (https=) |
| MX (1) | MX2021013248A (https=) |
| SG (1) | SG11202111748TA (https=) |
| TW (1) | TWI861099B (https=) |
| WO (1) | WO2020223435A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI761453B (zh) * | 2017-03-01 | 2022-04-21 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
| WO2023039584A2 (en) * | 2021-09-13 | 2023-03-16 | Medimmune Limited | Prevention of respiratory syncytial virus lower respiratory tract infection with nirsevimab |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| PE20091174A1 (es) * | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| LT2950886T (lt) | 2013-02-01 | 2020-07-10 | Medimmune, Llc | Respiracinio sincitinio viruso f baltymo epitopai |
| FR3008921B1 (fr) | 2013-07-23 | 2015-12-25 | Safran | Piece en materiau composite avec portion de conductivite thermique et electrique et procede de fabrication d'une telle piece |
| EP4353316A3 (en) | 2014-01-15 | 2024-08-21 | Medimmune Limited | Rsv-specific antibodies and functional parts thereof |
| BR112019018022A2 (pt) | 2017-03-01 | 2020-06-02 | Medimmune Limited | Formulações de anticorpos monoclonais |
| TWI761453B (zh) | 2017-03-01 | 2022-04-21 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
-
2020
- 2020-04-27 US US16/859,750 patent/US12024553B2/en active Active
- 2020-04-30 AU AU2020265676A patent/AU2020265676A1/en active Pending
- 2020-04-30 MX MX2021013248A patent/MX2021013248A/es unknown
- 2020-04-30 US US17/606,614 patent/US20220204593A1/en active Pending
- 2020-04-30 TW TW109114519A patent/TWI861099B/zh active
- 2020-04-30 CA CA3138180A patent/CA3138180A1/en active Pending
- 2020-04-30 EA EA202192776A patent/EA202192776A1/ru unknown
- 2020-04-30 CN CN202080032470.XA patent/CN113825767A/zh active Pending
- 2020-04-30 WO PCT/US2020/030619 patent/WO2020223435A1/en not_active Ceased
- 2020-04-30 BR BR112021020846A patent/BR112021020846A2/pt unknown
- 2020-04-30 KR KR1020217038129A patent/KR20220002427A/ko active Pending
- 2020-04-30 JP JP2021564373A patent/JP2022531205A/ja active Pending
- 2020-04-30 SG SG11202111748TA patent/SG11202111748TA/en unknown
- 2020-04-30 EP EP20727466.3A patent/EP3962940A1/en active Pending
-
2021
- 2021-10-20 IL IL287443A patent/IL287443A/en unknown
- 2021-10-26 CO CONC2021/0014370A patent/CO2021014370A2/es unknown
-
2024
- 2024-05-20 US US18/669,241 patent/US20240417447A1/en active Pending
-
2025
- 2025-01-31 JP JP2025014950A patent/JP2025072444A/ja active Pending